Masterplan competes for full serviceWhen independent service organizations (ISOs) practically ruled the technology management world a decade ago, Masterplan was one of many regional and national companies servicing biomedical and
Masterplan competes for full service
When independent service organizations (ISOs) practically ruled the technology management world a decade ago, Masterplan was one of many regional and national companies servicing biomedical and imaging equipment. Now the Chatsworth, CA, firm is the only national ISO left standing. But rather than looking for a graceful exit or a comfortable niche, the company is dusting off an old battle plan.
"OEMs represent the highest price point for service. It's the highest cost option hospitals have. Our goal is to provide world-class service but under a reduced cost structure, which helps hospitals save money and lower their operating expenses," said Adam Coffee, Masterplan president.
The company has distinguished itself from dinosaur ISOs by developing a self-reliant diagnostic imaging capability. Masterplan is a microcosm of the OEMs, offering the same types of direct service contracts as OEMs for both biomedical and diagnostic equipment, according to Coffee. Competing ISOs, in contrast, typically offer only first-call service on imaging and turn to OEMs to perform the actual maintenance on a time and materials basis.
That dynamic just no longer works for companies that want to do multivendor service, because they are at the mercy of OEM rate hikes for parts and labor. For an ISO to be successful, it must be able to supply its own competent diagnostic imaging technicians and eliminate the need to use the OEMs, said Bruce Cree, Masterplan CEO. That means an ISO has to be able to train technicians and supply them with parts and technical support.
Masterplan, which has a 27-year history in biomedical engineering, began strengthening its ability to service diagnostic imaging equipment several years ago by creating a diverse management team. The company hired Coffee away from GE Medical Systems about a year ago and added other senior managers with OEM and ISO experience as well as a former hospital CFO and a radiology director.
The company also developed a strategic alliance with ReMedPar of Goodlettsville, TN, to train Masterplan's engineers in servicing the full gamut of imaging equipment: x-ray, CT, MRI, nuclear medicine, ultrasound, and mammography.
The aggressive strategy appears to be working. Masterplan now provides multivendor service to more than 1000 facilities across the U.S. Clients include multihospital systems, such as Catholic Healthcare West, which operates 15 hospitals in southern California.
"Because we've been able to provide a service that's comparable to what the OEMs provide, we've seen a lot of success in the large hospital chain environment and the large facility environment, which recognize the value we add with similar products and services but at a lower cost point," Coffee said.
But Masterplan still faces stiff competition from the OEMs it emulates. Equipment manufacturers are striking back by keeping a lid on prices, said Victor Donohue, general manager of MDB Information Network of Dallas. OEMs can't afford to increase their service prices drastically when they are negotiating with a hospital over the purchase of a CT or MRI.
"It may be a service issue now, but it'll be a sales issue next time," Donohue said. "Hospitals will remember the vendors that rake them on service costs. Vendors have to be very cautious about their service costs because customers are looking at everything that drives costs up."
OEMs may even change the rules of engagement by blurring the line between service and equipment. Philips is experimenting with a plan whereby ultrasound customers sign a five-year agreement that covers service as well as upgrades (SCAN 5/1/02). That could give OEMs an advantage over ISOs by giving customers upgrades (which ISOs cannot), while improving customers' ability to budget for equipment upgrades--and to pay for services and upgrades incrementally over the term of the agreement.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.